Hemostemix Inc (TSE:HEM)
TSXV:HEM

Hemostemix (HEM) Income Statement

13 Followers

Hemostemix Income Statement

Last quarter (Q4 2023), Hemostemix's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, Hemostemix's net income was C$-475.53K. See Hemostemix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----C$ 0.00C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 1.35MC$ 2.16MC$ 4.63MC$ 6.66MC$ 7.47MC$ 4.70M
Operating Income
C$ -1.35MC$ -2.16MC$ -4.63MC$ -6.66MC$ -7.47MC$ -4.70M
Net Non Operating Interest Income Expense
C$ -600.25KC$ -556.12KC$ -306.20KC$ 20.85KC$ -113.03KC$ -104.98K
Other Income Expense
C$ -200.99KC$ -194.80KC$ -2.21KC$ 135.17KC$ -189.11KC$ -68.64K
Pretax Income
C$ -1.70MC$ -2.50MC$ -4.75MC$ -6.54MC$ -7.77MC$ -4.87M
Tax Provision
---C$ -255.78KC$ 0.00-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -1.70MC$ -2.50MC$ -4.75MC$ -6.29MC$ -7.77MC$ -4.87M
Basic EPS
C$ -0.02C$ -0.03C$ -0.07C$ -0.11C$ -0.24C$ -0.32
Diluted EPS
C$ -0.02C$ -0.03C$ -0.07C$ -0.11C$ -0.24C$ -0.32
Basic Average Shares
C$ 341.32MC$ 82.50MC$ 69.98MC$ 57.45MC$ 32.24MC$ 15.04M
Diluted Average Shares
C$ 341.32MC$ 82.50MC$ 69.98MC$ 57.45MC$ 32.24MC$ 15.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 288.41KC$ 231.97K
Total Expenses
C$ 1.35MC$ 2.16MC$ 4.63MC$ -6.66MC$ 7.47MC$ 4.70M
Net Income From Continuing And Discontinued Operation
C$ -1.70MC$ -2.50MC$ -4.75MC$ -6.29MC$ -7.77MC$ -4.87M
Normalized Income
C$ -1.37MC$ -1.84MC$ -3.49MC$ -6.80MC$ -7.58MC$ -4.80M
Interest Expense
----C$ 106.05KC$ 104.98K
EBIT
C$ -1.10MC$ -1.95MC$ -4.44MC$ -6.53MC$ -7.66MC$ -4.76M
EBITDA
C$ -1.10MC$ -1.95MC$ -4.44MC$ -6.53MC$ -7.66MC$ -4.76M
Currency in CAD

Hemostemix Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis